137 related articles for article (PubMed ID: 10513738)
1. Implication of fibrate therapy for homocysteine.
Goffin E; Jamar F; Desager JP; Devuyst O
Lancet; 1999 Oct; 354(9185):1209. PubMed ID: 10513738
[No Abstract] [Full Text] [Related]
2. Paradoxical high-density lipoprotein reduction induced by fenofibrate and ciprofibrate.
Collinson PO; Hjelm CJ; Canepo-Anson R
Ann Clin Biochem; 1996 Mar; 33 ( Pt 2)():159-61. PubMed ID: 8729728
[No Abstract] [Full Text] [Related]
3. The effects of fibrates on lipoprotein and hemostatic coronary risk factors.
Schonfeld G
Atherosclerosis; 1994 Dec; 111(2):161-74. PubMed ID: 7718018
[TBL] [Abstract][Full Text] [Related]
4. Effects of fenofibrate and gemfibrozil on plasma homocysteine.
Bostom AG
Lancet; 2001 Nov; 358(9295):1811-2. PubMed ID: 11734262
[No Abstract] [Full Text] [Related]
5. Fibrates and HDL cholesterol.
Murphy MJ; Packard CJ; O'Reilly DS
Ann Clin Biochem; 1997 Jan; 34 ( Pt 1)():114. PubMed ID: 9022900
[No Abstract] [Full Text] [Related]
6. Fibrates and renal function.
Gajdos M; Dzúrik R
Clin Nephrol; 2003 Jul; 60(1):65-6. PubMed ID: 12872864
[No Abstract] [Full Text] [Related]
7. [Treatment of familial combined hyperlipidemia].
Bruckert E
Ann Endocrinol (Paris); 1997; 58(4):297-301. PubMed ID: 9436478
[No Abstract] [Full Text] [Related]
8. Creatinine rise after fibrate therapy in renal graft recipients.
Devuyst O; Goffin E; Pirson Y; van Ypersele de Strihou C
Lancet; 1993 Mar; 341(8848):840. PubMed ID: 8096050
[No Abstract] [Full Text] [Related]
9. Fibrates and homocysteine.
Young IS; Woodside JV
Nutrition; 2001; 17(11-12):973-4. PubMed ID: 11744353
[No Abstract] [Full Text] [Related]
10. Abnormal lipid profiles on fibrate derivatives.
McLeod AJ; Warren RJ; Armitage M
Lancet; 1996 Jan; 347(8996):261. PubMed ID: 8551900
[No Abstract] [Full Text] [Related]
11. Drug interactions with fibric acids.
Lozada A; Dujovne CA
Pharmacol Ther; 1994 Aug; 63(2):163-76. PubMed ID: 7809177
[TBL] [Abstract][Full Text] [Related]
12. Effects of fibric acid derivatives on biliary lipid composition.
Palmer RH
Am J Med; 1987 Nov; 83(5B):37-43. PubMed ID: 3318452
[TBL] [Abstract][Full Text] [Related]
13. Effect of fenofibrate treatment for hyperlipidaemia on serum creatinine and cystatin C.
Ncube V; Starkey B; Wang T
Ann Clin Biochem; 2012 Sep; 49(Pt 5):491-3. PubMed ID: 22829698
[TBL] [Abstract][Full Text] [Related]
14. Fibrate treatment can increase serum creatinine levels.
Tsimihodimos V; Kakafika A; Elisaf M
Nephrol Dial Transplant; 2001 Jun; 16(6):1301. PubMed ID: 11390746
[No Abstract] [Full Text] [Related]
15. Lipid-lowering drugs and homocysteine.
Landray MJ; Townend JN; Martin S; Martin U; Wheeler DC
Lancet; 1999 Jun; 353(9168):1974-5. PubMed ID: 10371600
[No Abstract] [Full Text] [Related]
16. The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates.
Rizzo M; Berneis K
Curr Med Res Opin; 2007 May; 23(5):1103-11. PubMed ID: 17519077
[TBL] [Abstract][Full Text] [Related]
17. [Molecular pharmacology and medicinal chemistry of fibrate].
Steinhilber D; Schubert-Zsilavecz M
Pharm Unserer Zeit; 2007; 36(2):108-12. PubMed ID: 17424995
[No Abstract] [Full Text] [Related]
18. Lipid profiles on fibric-acid derivatives.
Capps NE
Lancet; 1994 Sep; 344(8923):684-5. PubMed ID: 7915370
[No Abstract] [Full Text] [Related]
19. Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?
Broeders N; Knoop C; Antoine M; Tielemans C; Abramowicz D
Nephrol Dial Transplant; 2000 Dec; 15(12):1993-9. PubMed ID: 11096145
[TBL] [Abstract][Full Text] [Related]
20. Fibrate-induced increase in blood urea and creatinine.
Lipscombe J; Bargman JM
Nephrol Dial Transplant; 2001 Jul; 16(7):1515. PubMed ID: 11427661
[No Abstract] [Full Text] [Related]
[Next] [New Search]
